Kenvue announces FDA approval of BEMT sunscreen ingredient
The FDA order issued June 10, 2026, allows BEMT use in US sunscreens effective Aug 9, 2026.
See the latest news and media coverage for Kenvue. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global consumer health company
kenvue.comLast updated
In short: Kenvue moved toward a $48.7 billion merger with Kimberly-Clark, reported Q1 2026 growth, and faced several legal challenges regarding its brands.
The FDA order issued June 10, 2026, allows BEMT use in US sunscreens effective Aug 9, 2026.
Net sales grew 4.5% to $3.9B, organic sales up 0.7%, adjusted diluted EPS up 33% to $0.32.
Net sales rose 4.5% with organic growth of 0.7%. Diluted EPS increased to $0.25. Pending merger with Kimberly-Clark awaits approvals.
The announcement provides clarity and momentum for the Kenvue-Kimberly-Clark combination, closing in late 2026. It builds a global health and wellness leader.
Kenvue Inc., formerly part of Johnson & Johnson, is a pure-play consumer health company. The company has three segments: Self Care, Skin Health & Beauty...
Kenvue shares remain in focus as investors weigh the consumer-health company’s fundamentals, dividend profile and valuation after its 2023 spin-off from Johnson & Johnson and...
It is unclear whether a widespread "Benadryl Challenge" is related to the uptick in overdoses;...
Kenvue Inc operates in consumer health markets with diversified product categories and inclusion in the S&P 500 Index, reflecting its presence in global consumer staples.
Track Kenvue and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Kenvue and other trending companies.